Integrating T cell metabolism in cancer immunotherapy

Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2017-12, Vol.411, p.12-18
Hauptverfasser: Dugnani, Erica, Pasquale, Valentina, Bordignon, Carlotta, Canu, Adriana, Piemonti, Lorenzo, Monti, Paolo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 18
container_issue
container_start_page 12
container_title Cancer letters
container_volume 411
creator Dugnani, Erica
Pasquale, Valentina
Bordignon, Carlotta
Canu, Adriana
Piemonti, Lorenzo
Monti, Paolo
description Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiation into different cell subsets, effector function and development of long-lasting memory. This provides an opportunity to improve the T cell response through manipulation of metabolism, which is instrumental to ameliorate the current protocols for cancer immunotherapy. Using drugs and molecules targeting selective metabolic pathways it is now possible to generate T cells that can mount a durable and stable anti-tumor response. On the other hand, cancer cells can take advantage of the metabolic requirements of T cells to evade the immune response. In this brief review we discuss recent findings of T cell metabolism in quiescence and activation, how the tumor microenvironment can affect T cell metabolism, and how T cell metabolism can be manipulated to improve the T cell response to tumors. •T cell activation, function and persistence depends on metabolic fitness.•T cell metabolism can be targeted to improve anti-tumor T cell response.•T cells using mitochondrial oxidative metabolism have improved anti-tumor activity.•The tumor microenvironement impairs T cell metabolic fitness.
doi_str_mv 10.1016/j.canlet.2017.09.039
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1947096910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383517306006</els_id><sourcerecordid>1947096910</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-6c99102964281e60dc75302c7f5980882dbff5010d0db8205e701055fb0286ad3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo7vrxD0QKXry0TtKkSS6CLH4sCF70HNp0qln6sSatsP_eLLt68OBpGHhm3peHkAsKGQVa3KwyW_YtjhkDKjPQGeT6gMypkiyVWsEhmUMOPM1VLmbkJIQVAAguxTGZMaUl51zNiVj2I777cnT9e_KaWGzbpMOxrIbWhS5xfRJTLPrEdd3UD-MH-nK9OSNHTdkGPN_PU_L2cP-6eEqfXx6Xi7vn1OYaxrSwWlNguuBMUSygtlLkwKxsRCyoFKurphFAoYa6UgwEyrgI0VTAVFHW-Sm53v1d--FzwjCazoVtx7LHYQqGai5BFzEkold_0NUw-T62i1QheF5QxiLFd5T1QwgeG7P2riv9xlAwW61mZXZazVarAW2i1nh2uX8-VR3Wv0c_HiNwuwMw2vhy6E2wDqO42nm0o6kH93_CN4zziAI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1965436122</pqid></control><display><type>article</type><title>Integrating T cell metabolism in cancer immunotherapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Dugnani, Erica ; Pasquale, Valentina ; Bordignon, Carlotta ; Canu, Adriana ; Piemonti, Lorenzo ; Monti, Paolo</creator><creatorcontrib>Dugnani, Erica ; Pasquale, Valentina ; Bordignon, Carlotta ; Canu, Adriana ; Piemonti, Lorenzo ; Monti, Paolo</creatorcontrib><description>Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiation into different cell subsets, effector function and development of long-lasting memory. This provides an opportunity to improve the T cell response through manipulation of metabolism, which is instrumental to ameliorate the current protocols for cancer immunotherapy. Using drugs and molecules targeting selective metabolic pathways it is now possible to generate T cells that can mount a durable and stable anti-tumor response. On the other hand, cancer cells can take advantage of the metabolic requirements of T cells to evade the immune response. In this brief review we discuss recent findings of T cell metabolism in quiescence and activation, how the tumor microenvironment can affect T cell metabolism, and how T cell metabolism can be manipulated to improve the T cell response to tumors. •T cell activation, function and persistence depends on metabolic fitness.•T cell metabolism can be targeted to improve anti-tumor T cell response.•T cells using mitochondrial oxidative metabolism have improved anti-tumor activity.•The tumor microenvironement impairs T cell metabolic fitness.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2017.09.039</identifier><identifier>PMID: 28974448</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Animals ; Antigens ; Biosynthesis ; Cancer ; Cancer immunotherapy ; Cell activation ; Cell Differentiation - immunology ; Cell growth ; Cell survival ; Cytokines ; Drug delivery ; Energy ; Fatty acids ; Glycerol ; Humans ; Immune response ; Immuno-metabolism ; Immunosuppressive agents ; Immunotherapy ; Immunotherapy - methods ; Long term memory ; Lymphocyte Activation ; Lymphocytes ; Lymphocytes T ; Metabolic pathways ; Metabolism ; Metabolites ; Neoplasms - immunology ; Neoplasms - metabolism ; Neoplasms - therapy ; Phosphorylation ; Substrates ; T cell receptors ; T cells ; T-Lymphocytes - immunology ; T-Lymphocytes - metabolism ; Tumors</subject><ispartof>Cancer letters, 2017-12, Vol.411, p.12-18</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 28, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-6c99102964281e60dc75302c7f5980882dbff5010d0db8205e701055fb0286ad3</citedby><cites>FETCH-LOGICAL-c390t-6c99102964281e60dc75302c7f5980882dbff5010d0db8205e701055fb0286ad3</cites><orcidid>0000-0002-4452-2164</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.canlet.2017.09.039$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28974448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dugnani, Erica</creatorcontrib><creatorcontrib>Pasquale, Valentina</creatorcontrib><creatorcontrib>Bordignon, Carlotta</creatorcontrib><creatorcontrib>Canu, Adriana</creatorcontrib><creatorcontrib>Piemonti, Lorenzo</creatorcontrib><creatorcontrib>Monti, Paolo</creatorcontrib><title>Integrating T cell metabolism in cancer immunotherapy</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiation into different cell subsets, effector function and development of long-lasting memory. This provides an opportunity to improve the T cell response through manipulation of metabolism, which is instrumental to ameliorate the current protocols for cancer immunotherapy. Using drugs and molecules targeting selective metabolic pathways it is now possible to generate T cells that can mount a durable and stable anti-tumor response. On the other hand, cancer cells can take advantage of the metabolic requirements of T cells to evade the immune response. In this brief review we discuss recent findings of T cell metabolism in quiescence and activation, how the tumor microenvironment can affect T cell metabolism, and how T cell metabolism can be manipulated to improve the T cell response to tumors. •T cell activation, function and persistence depends on metabolic fitness.•T cell metabolism can be targeted to improve anti-tumor T cell response.•T cells using mitochondrial oxidative metabolism have improved anti-tumor activity.•The tumor microenvironement impairs T cell metabolic fitness.</description><subject>Animals</subject><subject>Antigens</subject><subject>Biosynthesis</subject><subject>Cancer</subject><subject>Cancer immunotherapy</subject><subject>Cell activation</subject><subject>Cell Differentiation - immunology</subject><subject>Cell growth</subject><subject>Cell survival</subject><subject>Cytokines</subject><subject>Drug delivery</subject><subject>Energy</subject><subject>Fatty acids</subject><subject>Glycerol</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immuno-metabolism</subject><subject>Immunosuppressive agents</subject><subject>Immunotherapy</subject><subject>Immunotherapy - methods</subject><subject>Long term memory</subject><subject>Lymphocyte Activation</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Metabolic pathways</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - therapy</subject><subject>Phosphorylation</subject><subject>Substrates</subject><subject>T cell receptors</subject><subject>T cells</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes - metabolism</subject><subject>Tumors</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo7vrxD0QKXry0TtKkSS6CLH4sCF70HNp0qln6sSatsP_eLLt68OBpGHhm3peHkAsKGQVa3KwyW_YtjhkDKjPQGeT6gMypkiyVWsEhmUMOPM1VLmbkJIQVAAguxTGZMaUl51zNiVj2I777cnT9e_KaWGzbpMOxrIbWhS5xfRJTLPrEdd3UD-MH-nK9OSNHTdkGPN_PU_L2cP-6eEqfXx6Xi7vn1OYaxrSwWlNguuBMUSygtlLkwKxsRCyoFKurphFAoYa6UgwEyrgI0VTAVFHW-Sm53v1d--FzwjCazoVtx7LHYQqGai5BFzEkold_0NUw-T62i1QheF5QxiLFd5T1QwgeG7P2riv9xlAwW61mZXZazVarAW2i1nh2uX8-VR3Wv0c_HiNwuwMw2vhy6E2wDqO42nm0o6kH93_CN4zziAI</recordid><startdate>20171228</startdate><enddate>20171228</enddate><creator>Dugnani, Erica</creator><creator>Pasquale, Valentina</creator><creator>Bordignon, Carlotta</creator><creator>Canu, Adriana</creator><creator>Piemonti, Lorenzo</creator><creator>Monti, Paolo</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4452-2164</orcidid></search><sort><creationdate>20171228</creationdate><title>Integrating T cell metabolism in cancer immunotherapy</title><author>Dugnani, Erica ; Pasquale, Valentina ; Bordignon, Carlotta ; Canu, Adriana ; Piemonti, Lorenzo ; Monti, Paolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-6c99102964281e60dc75302c7f5980882dbff5010d0db8205e701055fb0286ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Antigens</topic><topic>Biosynthesis</topic><topic>Cancer</topic><topic>Cancer immunotherapy</topic><topic>Cell activation</topic><topic>Cell Differentiation - immunology</topic><topic>Cell growth</topic><topic>Cell survival</topic><topic>Cytokines</topic><topic>Drug delivery</topic><topic>Energy</topic><topic>Fatty acids</topic><topic>Glycerol</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immuno-metabolism</topic><topic>Immunosuppressive agents</topic><topic>Immunotherapy</topic><topic>Immunotherapy - methods</topic><topic>Long term memory</topic><topic>Lymphocyte Activation</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Metabolic pathways</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - therapy</topic><topic>Phosphorylation</topic><topic>Substrates</topic><topic>T cell receptors</topic><topic>T cells</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dugnani, Erica</creatorcontrib><creatorcontrib>Pasquale, Valentina</creatorcontrib><creatorcontrib>Bordignon, Carlotta</creatorcontrib><creatorcontrib>Canu, Adriana</creatorcontrib><creatorcontrib>Piemonti, Lorenzo</creatorcontrib><creatorcontrib>Monti, Paolo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dugnani, Erica</au><au>Pasquale, Valentina</au><au>Bordignon, Carlotta</au><au>Canu, Adriana</au><au>Piemonti, Lorenzo</au><au>Monti, Paolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrating T cell metabolism in cancer immunotherapy</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2017-12-28</date><risdate>2017</risdate><volume>411</volume><spage>12</spage><epage>18</epage><pages>12-18</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Activation and maintenance of the T cell response occurs concurrently with metabolic reprogramming. This ensures the T cell response is supported by sufficient energy and substrates necessary for cell survival, growth and proliferation. Different metabolic programs are associated with differentiation into different cell subsets, effector function and development of long-lasting memory. This provides an opportunity to improve the T cell response through manipulation of metabolism, which is instrumental to ameliorate the current protocols for cancer immunotherapy. Using drugs and molecules targeting selective metabolic pathways it is now possible to generate T cells that can mount a durable and stable anti-tumor response. On the other hand, cancer cells can take advantage of the metabolic requirements of T cells to evade the immune response. In this brief review we discuss recent findings of T cell metabolism in quiescence and activation, how the tumor microenvironment can affect T cell metabolism, and how T cell metabolism can be manipulated to improve the T cell response to tumors. •T cell activation, function and persistence depends on metabolic fitness.•T cell metabolism can be targeted to improve anti-tumor T cell response.•T cells using mitochondrial oxidative metabolism have improved anti-tumor activity.•The tumor microenvironement impairs T cell metabolic fitness.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>28974448</pmid><doi>10.1016/j.canlet.2017.09.039</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-4452-2164</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2017-12, Vol.411, p.12-18
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_1947096910
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Antigens
Biosynthesis
Cancer
Cancer immunotherapy
Cell activation
Cell Differentiation - immunology
Cell growth
Cell survival
Cytokines
Drug delivery
Energy
Fatty acids
Glycerol
Humans
Immune response
Immuno-metabolism
Immunosuppressive agents
Immunotherapy
Immunotherapy - methods
Long term memory
Lymphocyte Activation
Lymphocytes
Lymphocytes T
Metabolic pathways
Metabolism
Metabolites
Neoplasms - immunology
Neoplasms - metabolism
Neoplasms - therapy
Phosphorylation
Substrates
T cell receptors
T cells
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Tumors
title Integrating T cell metabolism in cancer immunotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T20%3A59%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrating%20T%20cell%20metabolism%20in%20cancer%20immunotherapy&rft.jtitle=Cancer%20letters&rft.au=Dugnani,%20Erica&rft.date=2017-12-28&rft.volume=411&rft.spage=12&rft.epage=18&rft.pages=12-18&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2017.09.039&rft_dat=%3Cproquest_cross%3E1947096910%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1965436122&rft_id=info:pmid/28974448&rft_els_id=S0304383517306006&rfr_iscdi=true